Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily extended-release versus twice-daily immediate-release methylphenidate for adherence in children and adolescents with ADHD
ISRCTN93724387Phase 4Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Johannes Gutenberg University Mainz. Primary endpoint: Number of non-adherent days during the 100-day clinical trial. Started Mar 2009; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ISRCTN93724387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN93724387.